Емпафел

Empagliflozin is an oral medication used to support blood sugar management in adults with type 2 diabetes. It belongs to the SGLT2 inhibitor class and is taken once daily. Empagliflozin helps regulate glucose levels by promoting sugar removal through urine.

Empagliflozin is primarily used to improve blood sugar control in people with type 2 diabetes. It works alongside diet and exercise to lower blood glucose levels. Some patients may also use it to reduce the risk of cardiovascular events. It is not intended for type 1 diabetes or diabetic ketoacidosis.

Many users notice improved energy levels and fewer sugar cravings after starting empagliflozin. Some people report mild increases in urination early in treatment as the body adjusts. Hydration and balanced meals can help manage these effects.

Empagliflozin should be taken as prescribed, typically with the first meal of the day. Staying well-hydrated helps reduce the risk of side effects like low blood pressure. People with kidney issues should discuss use with a healthcare provider before starting.

Certain medications, such as diuretics or insulin, may interact with empagliflozin. Alcohol use may increase the risk of dehydration or low blood sugar. Always inform your doctor about all medications and supplements you are taking.